Pharma Industry Focuses on Accountability and Supply Chain Security

This week, Merck made headlines by diversifying its pipeline, signaling a strategic shift in its research and development focus. Meanwhile, the United States Pharmacopeia (USP) placed a strong emphasis on supply chain security, urging the pharmaceutical industry to adopt more robust measures to safeguard the integrity of its products.

The role of artificial intelligence (AI) in pharmaceuticals came under scrutiny, with discussions centering on the need for accountability in AI-driven systems. Experts argued that the industry must implement mechanisms to identify and correct errors before they impact patients.

Looking ahead, speakers previewed their presentations for upcoming industry events, including CPHI Milan and AAPS PharmSci 360. These events are expected to highlight innovations and challenges in the pharmaceutical sector, particularly around accountability and quality assurance.